Literature DB >> 3004636

Rare cancers and specialist centres.

R T Oliver.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3004636      PMCID： PMC1339633          DOI： 10.1136/bmj.292.6521.641

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  18 in total

1.  Chemotherapy of metastatic testicular tumours.

Authors:  R T Oliver; A A Rohatiner; P F Wrigley; J S Malpas
Journal:  Br J Urol       Date:  1980-02

2.  Hazards of combined beta-blocker/diuretic tablets.

Authors:  O Odugbesan; I M Chesner; G Bailey; A H Barnett
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

3.  Justification of the use of surveillance in the management of Stage I germ cell tumours of the testis.

Authors:  R T Oliver; H F Hope-Stone; J P Blandy
Journal:  Br J Urol       Date:  1983-12

Review 4.  The lymphomas--current management.

Authors:  T A Lister; J S Malpas
Journal:  Postgrad Med J       Date:  1983-04       Impact factor: 2.401

5.  Why retroperitoneal lymphadenectomy for testicular tumors?

Authors:  W L Caldwell
Journal:  South Med J       Date:  1969-10       Impact factor: 0.954

Review 6.  The treatment of acute myelogenous leukemia in adults.

Authors:  T A Lister; A Z Rohatiner
Journal:  Semin Hematol       Date:  1982-07       Impact factor: 3.851

7.  VAB-6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis.

Authors:  D Vugrin; W F Whitmore; R B Golbey
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

8.  Orchiectomy alone for Stage I testicular non-seminoma. A progress report on the Royal Marsden Hospital study.

Authors:  M J Peckham; A Barrett; A Horwich; W F Hendry
Journal:  Br J Urol       Date:  1983-12

9.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

10.  The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).

Authors:  M J Peckham; A Barrett; K H Liew; A Horwich; B Robinson; H J Dobbs; T J McElwain; W F Hendry
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640
View more
  5 in total

1.  Survival of patients with cancer.

Authors:  C A Stiller
Journal:  BMJ       Date:  1989-10-28

2.  Centralisation of treatment and survival rates for cancer.

Authors:  C A Stiller
Journal:  Arch Dis Child       Date:  1988-01       Impact factor: 3.791

3.  Occupation and testicular cancer.

Authors:  F L Williams
Journal:  J Epidemiol Community Health       Date:  1986-09       Impact factor: 3.710

Review 4.  The clinical potential of interleukin-2.

Authors:  R T Oliver
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

5.  Treatment and survival of lymphoid malignancy in the north-west of England: a population-based study.

Authors:  J H Youngson; J M Jones; J G Chang; M Harris; S S Banergee
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.